Introduction
Narcolepsy is a chronic neurological sleep disorder that affects the brain's ability to regulate sleep-wake cycles, resulting in excessive daytime sleepiness and often sudden, uncontrollable episodes of falling asleep during normal waking activities. It is a lifelong condition that, while not life-threatening, significantly impacts safety, productivity, relationships, and quality of life when not properly managed.
Causes
Type 1 narcolepsy (with cataplexy) is caused by the loss of hypocretin (orexin)-producing neurons in the hypothalamus, a brain region that regulates alertness and sleep. This loss is believed to result from an autoimmune process in genetically predisposed individuals. Type 2 narcolepsy (without cataplexy) has a less clear etiology, though similar neurological disruptions in sleep regulation are implicated. Other contributing factors may include infections, head trauma, or hormonal changes.
Symptoms
The hallmark symptom is excessive daytime sleepiness, characterized by an overwhelming urge to sleep and "sleep attacks" that can occur at any time. Additional symptoms may include cataplexy (sudden loss of muscle tone triggered by strong emotions such as laughter or surprise), sleep paralysis, hypnagogic or hypnopompic hallucinations (vivid dream-like experiences at sleep onset or awakening), and fragmented nighttime sleep.
Diagnosis
Diagnosis typically involves an overnight sleep study (polysomnography) followed by a Multiple Sleep Latency Test (MSLT) to measure how quickly the individual falls asleep and whether they enter REM sleep rapidly. A thorough clinical history is essential. In some cases, cerebrospinal fluid (CSF) analysis to measure hypocretin levels may be used to confirm Type 1 narcolepsy. Differential diagnosis must rule out other causes of excessive sleepiness.
Treatment
Narcolepsy is managed rather than cured. Treatment includes scheduled naps, good sleep hygiene, and avoidance of sleep deprivation. Medications include stimulants (modafinil, armodafinil, or amphetamines) to promote wakefulness and sodium oxybate (Xyrem/Lumryz) to consolidate nighttime sleep and reduce cataplexy. Antidepressants may be used to control cataplexy and REM-related symptoms. Behavioral strategies and workplace or school accommodations are also important.
This information is intended for educational and informational purposes only. It should not be used in place of an individual consultation or examination or replace the advice of your health care professional and should not be relied upon to determine diagnosis or course of treatment.